JAMDA
February 25, 2016
Showing 841 - 850 of 7965 results
JAMDA
June 22, 2018
Antipsychotic Deprescription for Older Adults in Long-term Care: The HALT Study
Despite limited efficacy and significant safety concerns, antipsychotic medications are frequently used to treat behavioral and psychological symptoms of dementia (BPSD) in long-term residential care. This study evaluates the sustained reduction of antipsychotic use for BPSD through a deprescribing interve...
JAMDA
September 25, 2023
Antipsychotic Drug Reduction through the Implementation of a Neurologically Oriented, Interdisciplinary Psycho-Diagnostic and Antipsychotic Stewardship Program
Antipsychotic utilization in skilled nursing facilities (SNFs) is a major focus of regulatory compliance and a key theme in resident care. This created opportunities for innovations in clinical care of behavioral and psychological symptoms of dementia (BPSD). In a shared initiative with one of our SNF oper...
JAMDA
February 27, 2016
Antipsychotic Drug Use Is Not Associated With Long-Term Mortality Risk in Norwegian Nursing Home Patients
To assess the long-term mortality risk associated with antipsychotic drug (AP) use in nursing homes.
JAMDA
August 4, 2020
Antipsychotic Drugs and Hip Fracture: Associations Before and After the Initiation of Treatment
To study the association between antipsychotic drug treatment and hip fracture, before and after the initiation of treatment.
JAMDA
February 25, 2020
Antipsychotic Drugs, Fracture Risk, and Frailty in Older Patients
Caring for the Ages
April 4, 2023
Antipsychotic Prescribing Varies Widely Among States
JAMDA
February 26, 2019
Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study
To assess all-cause mortality patients with dementia treated with typical and atypical antipsychotic drugs (APDs).
JAMDA
October 28, 2021
Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer’s Disease
Antipsychotic use for neuropsychiatric symptoms in Alzheimer’s disease (AD) is common despite the increased risk of cardiovascular events and mortality. There is limited and inconsistent evidence on the possible risk of stroke. We assessed whether antipsychotic initiation increases the risk of stroke in pe...
JAMDA
February 6, 2025